← back to search

Ute Fischer

Hospital Clínic de Barcelona · DE
Area of research
Immunology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Acute Lymphoblastic Leukemia research, Immunotherapy and Immune Responses, Immune cells in cancer, and Immunodeficiency and Autoimmune Disorders.
h-index
44
citations
5,116
works
226
NIH funding
primary concept
Biology
email

Recent publications

Epigenetic remodeling via HDAC6 inhibition amplifies anti-tumoral immune responses in myeloid leukemia cells.
2026cited by 0position: contributordoi
A gut instinct for childhood leukemia prevention: microbiome-targeting recommendations aimed at parents and caregivers
Frontiers in Public Health 2025cited by 4position: lastdoi
H1‐0 is a specific mediator of the repressive ETV6::RUNX1 transcriptional landscape in preleukemia and B cell acute lymphoblastic leukemia
HemaSphere 2025cited by 4position: lastdoi
H1-0 is a specific mediator of the repressive ETV6::RUNX1 transcriptional landscape in preleukemia and B cell acute lymphoblastic leukemia.
2025cited by 4position: contributordoi
Deep transfer learning approach for automated cell death classification reveals novel ferroptosis-inducing agents in subsets of B-ALL
Cell Death and Disease 2025cited by 3position: middledoi
Immune training enhances anti-viral responses and improves outcomes in Pax5<sup>-/+</sup> mice susceptible to chronic infection.
2025cited by 2position: contributordoi
Deep transfer learning approach for automated cell death classification reveals novel ferroptosis-inducing agents in subsets of B-ALL.
2025cited by 1position: contributordoi
Modulation of the <i>ETV6::RUNX1</i> Gene Fusion Prevalence in Newborns by Corticosteroid Use During Pregnancy.
2025cited by 1position: contributordoi
Epigenetic remodeling via HDAC6 inhibition amplifies anti-tumoral immune responses in myeloid leukemia cells
2025cited by 0position: contributordoi
Serum-free differentiation platform for the generation of B lymphocytes and natural killer cells from human CD34+ cord blood progenitors
2025cited by 0position: contributordoi
Supplementary Figure 2 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
2025cited by 0position: contributordoi
Supplementary Table 3 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
2025cited by 0position: contributordoi
Supplementary Figure7 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
2025cited by 0position: contributordoi
Supplementary Figure 6 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
2025cited by 0position: contributordoi
Supplementary Figure 3 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
2025cited by 0position: contributordoi
Supplementary materials and methods from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
2025cited by 0position: contributordoi
Supplementary Figure 5 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
2025cited by 0position: contributordoi
Supplementary Figure 1 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
2025cited by 0position: contributordoi
Supplementary Table 1 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
2025cited by 0position: contributordoi
Supplementary Figure 4 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
2025cited by 0position: contributordoi
Supplementary Table 2 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
2025cited by 0position: contributordoi
A brain organoid/ALL coculture model reveals the AP-1 pathway as critically associated with CNS involvement of BCP-ALL.
2024cited by 6position: contributordoi
Optical genome mapping identifies structural variants in potentially new cancer predisposition candidate genes in pediatric cancer patients.
2024cited by 4position: contributordoi
A gut instinct for childhood leukemia prevention: microbiome-targeting recommendations aimed at parents and caregivers.
2024cited by 3position: contributordoi
Maternal Lifestyle and Prenatal Risk Factors for Childhood Leukemia: A Review of the Existing Evidence.
2024cited by 3position: contributordoi
Hyperdiploid acute lymphoblastic leukemia in children with <i>LZTR1</i> germline variants.
2024cited by 3position: contributordoi
Proteogenomic profiling uncovers differential therapeutic vulnerabilities between TCF3::PBX1 and TCF3::HLF translocated B-cell acute lymphoblastic leukemia
Haematologica 2024cited by 2position: lastdoi
Proteogenomic profiling uncovers differential therapeutic vulnerabilities between <i>TCF3::PBX1</i> and <i>TCF3::HLF</i> translocated B-cell acute lymphoblastic leukemia.
2024cited by 1position: contributordoi
Linker histone H1-0 is a specific mediator of the repressive ETV6::RUNX1 transcriptional landscape
2024cited by 0position: contributordoi
Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome.
2023cited by 95position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 46 papers (2021–2026)Daniel Picard · Hochschule Düsseldorf University of Applied Sciences38 papers (2022–2025)Renata Varaljai · Essen University Hospital36 papers (2022–2025)Anke Van Lierop · Düsseldorf University Hospital36 papers (2022–2025) · 36 papers (2022–2025)Nikkitha Umesh Ganesh · Massachusetts General Hospital36 papers (2022–2025)Dieter Häussinger · Heinrich Heine University Düsseldorf36 papers (2022–2025)Arndt Borkhardt · Düsseldorf University Hospital22 papers (2013–2025)Arndt Borkhardt · Heinrich Heine University Düsseldorf15 papers (2019–2026)Marc Remke · University Research Co (United States)11 papers (2021–2025)Daniel Picard · Universitätsklinikum des Saarlandes9 papers (2018–2025)Marc Remke · Saarland University8 papers (2018–2024)Jasmin Bartl · Düsseldorf University Hospital7 papers (2018–2024)Julia Hauer · München Klinik Schwabing6 papers (2017–2021)Guido Reifenberger · University of Toronto6 papers (2013–2021)Rabea Wagener · Universität Ulm5 papers (2021–2024)David Pauck · Düsseldorf University Hospital5 papers (2018–2021) · 5 papers (2023–2026)Lena Blümel · Düsseldorf University Hospital5 papers (2018–2024)Nan Qin · Henan University of Traditional Chinese Medicine5 papers (2019–2024)